Florida H0697 aims to regulate prescription drug prices and coverage by establishing reference prices and limiting changes to drug formularies.
Florida H0697, titled the "Prescription Reduction Incentives and Competition Enhancement Act," establishes a framework for regulating prescription drug prices and coverage. The bill mandates the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze international drug price data. It requires health insurers to limit prescription drug reimbursement to reference prices and use savings to reduce policyholder premiums and cost-sharing.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.